NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
CompletedNA
Sponsor: Vanderbilt University Medical Center
Conditions: COPD, Asthma
Interventions: Benefits investigation
Countries: United States
The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * Adult patient admitted to Vanderbilt University Medical Center (VUMC) (excluding surgery services) * on a long acting inhaler or prescribed a long acting inhaler during admission. Exclusion Criteria: * Diagnosis of cystic fibrosis * Diagnosis of graft versus host disease (GVHD) * no medication insurance * discharge to any post-acute care facility or inpatient hospice * death during hospitalization
Locations (1)
- Nashville, Tennessee, United States